SEC Filings | Enanta Pharmaceuticals, Inc.

SEC Filings

Filing date	Form	Description	Filing Group	View
Jan 28, 2021	DEFR14A	DEFR14A	Proxy Filings	View HTML 0001564590-21-003009.pdf 0001564590-21-003009.rtf 0001564590-21-003009.xls
Mar 20, 2013	EFFECT	EFFECT	Other	View HTML 9999999995-13-000755.pdf 9999999995-13-000755.rtf 9999999995-13-000755.xls
Feb 08, 2024	EFFECT	EFFECT	Other	View HTML 9999999995-24-000353.pdf 9999999995-24-000353.rtf 9999999995-24-000353.xls
Feb 10, 2022	NT 10-Q	Notification that form type 10-Q will be submitted late	Quarterly Filings	View HTML 0001193125-22-033095.pdf 0001193125-22-033095.rtf 0001193125-22-033095.xls
Nov 22, 2023	POSASR	POSASR	Other	View HTML 0001193125-23-282244.pdf 0001193125-23-282244.rtf
Jun 21, 2002	REGDEX	REGDEX	Other	View HTML 9999999997-02-040214.pdf 9999999997-02-040214.rtf
Feb 05, 2013	S-1/A	Amended Registration statement for face-amount certificate companies	Registration Statements	View HTML 0001193125-13-038960.pdf 0001193125-13-038960.rtf 0001193125-13-038960.xls
Mar 05, 2013	S-1/A	Amended Registration statement for face-amount certificate companies	Registration Statements	View HTML 0001193125-13-091763.pdf 0001193125-13-091763.rtf 0001193125-13-091763.xls
Mar 14, 2013	S-1/A	Amended Registration statement for face-amount certificate companies	Registration Statements	View HTML 0001193125-13-107174.pdf 0001193125-13-107174.rtf 0001193125-13-107174.xls
Nov 22, 2023	S-3	Simplified registration form	Registration Statements	View HTML 0001193125-23-282292.pdf 0001193125-23-282292.rtf 0001193125-23-282292.xls

Data provided by Kaleidoscope.